Read more

February 22, 2022
5 min watch
Save

VIDEO: Vabysmo shows good durability in diabetic macular edema

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio Video Perspective, John A. Wells III, MD, discusses results from the YOSEMITE and RHINE studies of Vabysmo (faricimab, Genentech) to treat diabetic macular edema, presented at Angiogenesis, Exudation, and Degeneration 2022.